PharmiWeb.com - Global Pharma News & Resources
19-Jun-2019

Bioanalytical Testing Services Market to Cross USD 4.57 Billion by 2026

Global Bioanalytical Testing Services Market Size is expected to reach USD 4.57 Billion by 2026 and growing CAGR around 7.0 % during the forecast period.

The global Bioanalytical Testing Services Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2019 to 2026. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2019 to 2026.

Request a Sample Copy of this Research Report athttps://www.acumenresearchandconsulting.com/request-sample/1301

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global Bioanalytical Testing Services Market.

Key Takeaways:

  • What is the market size in 2018 and the growth rate of the global Bioanalytical Testing Services Market?
  • What is the market drivers, restrains, opportunities governing the global Bioanalytical Testing Services Market?
  • Which is the largest and the fastest growing segments in the global Bioanalytical Testing Services Market?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

Market Players:

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market. The Bioanalytical Testing Services Market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players of the market are PSC, SGS SA, Toxikon, Inc., The Intertech group, Pace Analytical Services, SLC, PPD; ICON plc; Covance Inc.; LabCorp; Charles River Laboratories International, Inc. and among others.

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1301

The Major Market Segments of GlobalBioanalytical Testing Services Marketare as below:

Market Segmentation

Market by Molecule Type

  • Large Molecule
    • Immunoassays
    • LC-MS Studies
    • Others
  • Small Molecule

Market by Test Type

  • ADME
    • In-Vitro
    • In-Vivo
  • PD
  • PK
  • Bioequivalence
  • Bioavailability
  • Others

Market, by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

The market research study on Bioanalytical Testing Services Market (By Molecule Type: Large Molecule [Immunoassays, LC-MS Studies,Others], Small Molecule; By Test Type: ADME [In-Vitro, In-Vivo], PD, PK, Bioequivalence, Bioavailability, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026offers detailed insights on global Bioanalytical Testing Services market segments with market dynamics and their impact. The report provides insights on global Bioanalytical Testing Services market by product, end use industry and major geographic regions. The report also covers basic technology development policies.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Bioanalytical Testing Services
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Bioanalytical Testing Services Market By Molecule Type
1.2.2.1. Global Bioanalytical Testing Services Market Revenue and Growth Rate Comparison By Molecule Type (2015-2026)
1.2.2.2. Global Bioanalytical Testing Services Market Revenue Share By Molecule Type in 2017
1.2.2.3. Large Molecule
1.2.2.3.1. Immunoassays
1.2.2.3.2. LC-MS Studies
1.2.2.3.3. Others
1.2.2.4. Small Molecule
1.2.2.5. Others
1.2.3. Bioanalytical Testing Services Market By Test Type
1.2.3.1. Global Bioanalytical Testing Services Market Revenue and Growth Rate Comparison By Test Type (2015-2026)
1.2.3.2. Global Bioanalytical Testing Services Market Revenue Share By Test Type in 2017
1.2.3.3. ADME
1.2.3.3.1. In-Vitro
1.2.3.3.2. In-Vivo
1.2.3.4. PD
1.2.3.5. PK
1.2.3.6. Bioequivalence
1.2.3.7. Bioavailability
1.2.3.8. Others
1.2.4. Bioanalytical Testing Services Market by Geography
1.2.4.1. Global Bioanalytical Testing Services Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Bioanalytical Testing Services Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Bioanalytical Testing Services Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Bioanalytical Testing Services Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Bioanalytical Testing Services Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Bioanalytical Testing Services Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Bioanalytical Testing Services Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Bioanalytical Testing Services Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Bioanalytical Testing Services Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Bioanalytical Testing Services Major Manufacturers in 2017

CHAPTER 4. BIOANALYTICAL TESTING SERVICES MARKET BY TYPE

4.1. Global Bioanalytical Testing Services Revenue By Molecule Type
4.2. Large Molecule
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. Immunoassays
4.2.4. LC-MS Studies
4.2.5. Others
4.3. Small Molecule
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Others
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. BIOANALYTICAL TESTING SERVICES MARKET BY APPLICATION

5.1. Global Bioanalytical Testing Services Revenue By Test Type
5.2. ADME
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.2.3. In-Vitro
5.2.4. In-Vivo
5.3. PD
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. PK
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Bioequivalence
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Bioavailability
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.7. Others
5.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY

6.1. North America Bioanalytical Testing Services Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Bioanalytical Testing Services Market Revenue Share Comparison, 2015 amp; 2026 (%)
6.3. U.S.
6.3.1. U.S. Bioanalytical Testing Services Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY

7.1. Europe Bioanalytical Testing Services Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Bioanalytical Testing Services Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY

8.1. Asia-Pacific Bioanalytical Testing Services Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Bioanalytical Testing Services Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY

9.1. Latin America Bioanalytical Testing Services Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Bioanalytical Testing Services Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY

10.1. Middle East Bioanalytical Testing Services Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Bioanalytical Testing Services Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY

11.1. Africa Bioanalytical Testing Services Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Bioanalytical Testing Services Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Molecule Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. PSC
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. SGS SA
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Toxikon, Inc.
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. The Intertech group
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Pace Analytical Services, LLC.
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. PPD
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. ICON plc
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Covance Inc.
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. LabCorp
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Charles River Laboratories International, Inc.
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Others
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1301

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 19-Jun-2019